Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference

February 20, 2024

https://www.globenewswire.com/news-release/2024/02/20/2831872/26106/en/Nuwellis-to-Announce-Late-Breaking-Clinical-Data-and-Host-Satellite-Symposium-at-Technology-and-Heart-Failure-Therapeutics-Conference.html

MINNEAPOLIS, Feb. 20, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq:NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced its planned activities at the upcoming Technology and Heart Failure Therapeutics conference (THT 2024), which is produced by the Cardiovascular Research Foundation (CRF), taking place March 4-6, in Boston.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.